Molecular typing of the pneumococcus and its application in epidemiology in sub-Saharan Africa by Eric S. Donkor
MINI REVIEW ARTICLE
published: 14 March 2013
doi: 10.3389/fcimb.2013.00012
Molecular typing of the pneumococcus and its application
in epidemiology in sub-Saharan Africa
Eric S. Donkor*
Department of Microbiology, University of Ghana Medical School, Accra, Ghana
Edited by:
D. S. Merrell, Uniformed Services
University, USA
Reviewed by:
Samantha J. King, The Ohio State
University, USA
Andrew Camilli, Tufts University,
USA
*Correspondence:
Eric S. Donkor, Department of
Microbiology, University of Ghana




Molecular typing of the pneumococcus has played a crucial role in understanding the
epidemiology of the organism. However, most of what is known about molecular
epidemiology of the pneumococcus pertains to the developed world. The brunt of
pneumococcal infections is borne by sub-Saharan African countries, which makes
epidemiological monitoring of the pneumococcus essential in this region of the world.
This review paper focuses on molecular typing of the pneumococcus and what is known
about epidemiology of the organism in sub-Saharan Africa based on the various typing
methods. Several molecular typing methods are available for typing the pneumococcus
and the major ones include multilocus sequence typing (MLST), multilocus enzyme
electrophoresis (MLEE), serotyping and DNA fingerprinting methods such as pulsed field
gel electrophoresis (PFGE) and amplified fragment length polymorphism (AFLP). Currently,
MLST is the most suitable method for typing the pneumococcus. The pneumococcal
population structure in sub-Saharan Africa appears to be quite different from that of the
developed world, and pneumococcal serotype 1 related to the ST 618 clone and clones of
the ST 217 clonal complex are responsible for outbreaks in sub-Saharan Africa.
Keywords: pneumococcus, multilocus sequence typing, sub-Saharan Africa, eBURST, epidemiology
INTRODUCTION
Streptococcus pneumoniae is part of the normal bacterial flora
of the upper respiratory tract, but is also associated with severe
invasive diseases, including meningitis, pneumonia, and septi-
caemia as well as non-invasive diseases such as otitis media
(Mitchell, 2006). An important feature of S. pneumoniae is the
presence of a polysaccharide capsule which is the basis of 94
serotypes of the organism (Henrichsen, 1995; Park et al., 2007;
Jin et al., 2009; Calix and Nahm, 2010). S. pneumoniae is a nat-
urally transformable organism, indicating that it can gain DNA
from exogenous sources and incorporate it into its genome. This
facilitates evolution of S. pneumoniae which occurs by horizon-
tal gene transfer and leads to evolutionary phenomena such as
capsular switching and antibiotic resistance. Occurrences of these
evolutionary phenomena as a result of pneumococcal conjugate
vaccinations have been documented (Brueggemann et al., 2007;
Pelton et al., 2007).
Molecular typing of bacterial pathogens has become very
important in studying the epidemiology of bacterial diseases, and
many of such typing schemes have been developed over the years.
For the pneumococcus, molecular typing has provided invaluable
insights into analyzing the clonal spread during epidemics, iden-
tifying infection route and transmission, and assessing evolution-
ary changes following vaccination (Spratt et al., 2004). However,
most of what is known about molecular epidemiology of the
pneumococcus emanates from the developed world. Majority
of pneumococcal infections occur in sub-Saharan Africa (Black
et al., 2010), which makes epidemiological monitoring of the
pneumococcus essential in this region of the world. Additionally,
massive pneumococcal vaccination is expected in sub-Saharan
Africa (PneumoADIP, 2007), and therefore a better understand-
ing of the genetic background of S. pneumoniae in the region is
required. This review paper summarizes the various molecular
methods used in typing the pneumococcus and what is known
about epidemiology of the organism in sub-Saharan Africa based
on the typing methods.
MOLECULAR TYPING METHODS OF Streptococcus
pneumoniae
SEROTYPING
Currently, the main S. pneumoniae serotyping methods include
the Quellung reaction, latex agglutination, and PCR-based meth-
ods. Quellung reaction is considered the gold standard for
serotyping of S. pneumoniae and other encapsulated bacteria such
as Klebsiella pneumoniae, Haemophilus influenzae, and Neisseria
meningitidis (Baek et al., 2011). Using the Quellung reaction
for serotyping is very reliable and reproducible, but also it is
labor-intensive. There are several types of the latex agglutina-
tion method used for serotyping of S. pneumoniae. However,
the latex agglutination test developed in 2004 by the Statens
Serum Institute in Denmark (Slotved et al., 2004) is used as
a standard method for pneumococcal serotyping in many lab-
oratories. Generally, the latex agglutination serotyping method
is simple and fast, but is not suitable for detecting multiple
serotype carriage. PCR-based serotyping methods exploit the
heterogeneity within the capsular operon of different serotypes
(Bentley et al., 2006). The first PCR-based serotyping technique
for S. pneumoniae was a single multiplex reaction developed by
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Brito et al. (2003) and could accurately determine six common
serotypes and two serogroups (collection of related serotypes).
Subsequent multiplex serotyping assays have been expanded to
cover more serotypes (Pai et al., 2006; Pimenta et al., 2009),
but up to a maximum of 33 can be identified based on the
method developed initially by Pai et al. (2006) and modified by
the Centre for Disease Control in Atlanta (http://www.cdc.gov/
ncidod/biotech/strep/pcr.htm). Generally, PCR-based serotyping
has been shown to be reliable and accurate, and can often be
used directly on clinical specimen. However, a key limitation
of current PCR-based typing methods is the inability to distin-
guish between many serotypes of the same serogroup (Brito et al.,
2003).
Recently, a microarray-based genomic tool for molecular
serotyping of S. pneumoniae based initially on the complete
sequences of the capsular loci of 91 serotypes has been developed
(Turner et al., 2011). The capsular microarray gives a high level of
serotyping accuracy (95–100%), but is limited in differentiating
some closely related serotypes (Turner et al., 2011).
Generally, serotyping has a poor discriminatory ability as it is
based on a single locus. Additionally, capsule switching has been
observed with the pneumococcus, which means that capsule does
not relate well to genetic background. The poor discriminatory
ability of serotyping makes it less useful for molecular epi-
demiological studies. Despite this, serotyping is likely to remain
an important typing method for pneumococci as both natural
immunity and current pneumococcal vaccines are based on the
capsule types of the organism.
Latex agglutination is the serotyping method used in most
microbiology laboratories in sub-Saharan Africa, and one sam-
ple cost about US$29. Serotyping by the Quellung reaction and
PCR cost about US$21 and US$8, respectively.
DNA FINGERPRINTINGMETHODS
These methods compare DNA fragment patterns generated
by restriction endonuclease enzymes, or in combination with
DNA PCR amplification. The various DNA fingerprinting meth-
ods of S. pneumoniae include Pulsed Field Gel Electrophoresis
(PFGE), Penicillin Binding Protein (PBP) Fingerprinting, BOX-
PCR, Restriction Fragment Length Polymorphism (RFLP), and
Amplified Fragment Length Polymorphism (AFLP). PFGE, a
genotypic method for the evaluation of total chromosomal DNA,
had been regarded as the “gold standard” for typing micro-
organisms (Schwartz and Cantor, 1984). PFGE has been reported
to have similar discriminatory ability as some PCR fingerprint-
ing methods such as BOX-PCR and RFLP (Yu et al., 2003).
AFLP has however, been reported to yield better discrimination
between pneumococcal and non-pneumococcal species com-
pared to PFGE (Neeleman et al., 2004). PFGE and other DNA
fingerprinting methods possess appreciable levels of discrimi-
nation and reproducibility, and can be used to address more
short term evolutionary questions. However, they are unsuitable
for population structure analyses as they index genetic varia-
tion whose origin are not properly understood and are under
diversifying selective pressure (Spratt, 1999). Additionally, the
DNA fingerprinting methods would be challenging to compare
between different laboratories.
MULTILOCUS ENZYME ELECTROPHORESIS
Multilocus enzyme electrophoresis (MLEE) explores the different
electrophoretic mobilities of a large number of cellular enzymes
encoded by house-keeping genes (Selander et al., 1986). MLEE
has a high discriminatory ability and also uses genetic variation
that is selectively neutral and accumulates slowly. These features
make MLEE highly efficient in population structure analysis of
bacteria, and in several studies, the technique has been success-
fully employed to investigate S. pneumoniae (Hall et al., 1996;
Combe et al., 2000). The main drawback of MLEE is that it
does not determine genotypes but phenotypes, which are sus-
ceptible to environmental influences. This can adversely affect
the reproducibility of MLEE results, and therefore, the MLEE
data sourced from different laboratories tends not be comparable.
Additionally, conservation of housekeeping genes makes MLEE
unsuitable for population studies of bacteria of a more clonal
population structure.
MULTILOCUS SEQUENCE TYPING
Multilocus sequence typing (MLST) shares the same principle
with MLEE but assigns alleles to housekeeping genes directly by
sequencing of those genes, and thus the level of resolution is
much better thanMLEE (Spratt, 1999). For each gene, the distinct
sequences present within a bacterial species such as S. pneumo-
niae, are assigned as distinct alleles, which are further used to
define an allelic profile or sequence type (ST) of a strain. So
far, over 8000 S. pneumoniae STs from a wide variety of geo-
graphical locations have been described in the S. pneumoniae
MLST database http://speumoniae.mlst.net/. However, there is
little MLST data on African isolates. The major advantage of
MLST is that sequence data is unambiguous and the STs of isolates
can be compared to those in a central database via the Internet,
in contrast to other typing methods which involve comparing
DNA fragment sizes on gels. Thus the portability of MLST means
it is highly useful in monitoring the population structure of a
given pathogen. Due to the sequence conservation in housekeep-
ing genes, sometimes MLST has limited ability to differentiate
bacterial strains, which limits its use in the epidemiological inves-
tigation of bacteria of a more clonal population structure. For
a naturally transformable organism like S. pneumoniae, MLST is
a valuable typing tool, as the high rates of recombination result
in a high rate of genetic diversification of pneumococcal popula-
tions (Brueggemann et al., 2004; Hanage et al., 2005). In terms of
cost, MLST is relatively more expensive compared to othermolec-
ular/genotyping methods such as MLEE and PFGE. It cost about
15 USD to analyze one pneumococcus sample by MLST, and a
complete analysis would also involve serotyping cost of US$29
(latex agglutination). The high cost ofMLST is likely to be amajor
limitation to its use in sub-Saharan Africa.
MOLECULAR EPIDEMIOLOGY OF S. pneumoniae
Over the years, the various molecular typing schemes of pneumo-
coccus have greatly facilitated our understanding of the molec-
ular epidemiology of the organism. Serotyping data indicates
that only a few of the discovered 94 serotypes are responsi-
ble for the vast majority of pneumococcal disease, and these
serotypes may vary from one geographical region to another
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(Hausdorff et al., 2000; Hausdorff, 2007). A recent global review
on pneumococcal serotypes causing invasive diseases in 51 coun-
tries showed that serotype 14 was the most common in all regions
including Africa, Asia, Europe, Latin America, Northern America,
andOceania (Johnston et al., 2010). In this review, it was observed
that seven serotypes (1, 5, 6A, 6B, 14, 19F, and 23F) accounted for
66–76% of diseases in each region, and the top eight serotypes in
Africa andAsia were the samewhich included, the seven serotypes
mentioned in addition to serotype 19A. It was also observed
that serotype 14 was the dominant serotype in younger children
(<23 months), while serotype 1 was the dominant serotype in
older children (24–59 months).
Genotyping of pneumococci has provided further insights into
the molecular epidemiology of pneumococcal serotypes. One of
such insights is that isolates of certain serotypes such as 1 and 7F
are associated with a limited number of clones, and these clones
are hardly observed with other serotypes (http://spneumoniae.
mlst.net/). On the other hand, serotypes such as 9V and 14
are associated with a wide variety of clonal types, which may
also be seen with some other serotypes (http://spneumoniae.
mlst.net/). The Pneumococcal Epidemiology Network (PMEN)
provides surveillance on epidemiologically significant clones and
currently, 43 such clones are known (http://www.sph.emory.edu/
PMEN/index.html).
In sub-Saharan Africa, most molecular epidemiological stud-
ies on S. pneumoniae have focused on serotype analysis (Cadoz
et al., 1981; Campbell et al., 2004; Traore et al., 2009; Donkor
et al., 2010) and the major serotypes reported by these studies
are similar to that reported generally for Africa (1, 5, 6A, 6B, 14,
19A, 19F, and 23F) by Johnston et al. (2010). Additionally, some
serotypes including 2, 9V, and 12 are also important causes of
invasive pneumococcal disease in the sub-region (Cadoz et al.,
1981; Campbell et al., 2004; Traore et al., 2009). As serotyp-
ing has a poor discriminatory ability unlike MLST, these studies
provide little information on molecular epidemiology of S. pneu-
moniae in sub-Saharan Africa. The few studies that have applied
genotyping to study S. pneumoniae in sub-Saharan Africa seem
to be more related to outbreaks situations. In The Gambia,
Antonio et al. (2008a) studied the molecular epidemiology of 127
invasive and carriage S. pneumoniae isolates from unvaccinated
children and children vaccinated with a nine valent pneumococ-
cal vaccine which had serotypes 1, 4, 5, 9V, 14, 18C, 19F, 23F,
and 6B). Twenty-seven different serotypes and 72 different STs
were identified, and there was no particular association of clones
with specific presentation of invasive pneumococcal disease. For
a given serotype, the genotype distribution varied considerably
between vaccinated and un-vaccinated children. However, the
population structure of serotype 1 obtained from vaccinated and
non-vaccinated children were the same and comprised mainly ST
618. In The Gambia, an outbreak of pneumococcal pneumonia
and septicaemia caused by serotype 1 occurred between 1997 and
2002 (Antonio et al., 2008b). In this outbreak, a 127 serotype
1 isolates were recovered and MLST showed that 72.7% of the
isolates were of ST 618. The other common serotype 1 clones
identified in this study were ST 3575 (9.4%), ST 217 (3.9%),
and ST 612 (2.4%). It was observed that ST 618 which caused
both pediatric and adult disease peaked annually in the hot dry
season, which was not observed for non-ST 618 clones. Prior to
the outbreak reported in The Gambia, ST 618 was implicated in a
meningitis outbreak in Burkina Faso over the period 2002–2005
(Yaro et al., 2006). In this outbreak, 249 (44%) of 571 cases of bac-
terial meningitis were caused by S. pneumoniae and the associated
case fatality rate was 46%. A total of 48 S. pneumoniae isolates
were serotyped, and 21 (44%) were found to be serotype 1. MLST
was carried out on only three of these serotype 1 isolates, and two
were found to be ST 618 with the other isolate being a novel ST,
and a single locus variant of ST 618. An outbreak of pneumo-
coccal meningitis similar to the outbreak in Burkina Faso also
occurred in Ghana during the period of 2002–2003 (Leimkugel
et al., 2005). In this outbreak, the case fatality was 44%, and exam-
ination of the S. pneumoniae isolates responsible for this outbreak
showed that 76% were of serotype 1 and were of three STs includ-
ing ST 217, and its 2 single-locus variants ST303 and ST612.
ST 217 which was the dominant clone in this outbreak is also
a double locus variant of ST618 responsible for pneumococcal
outbreaks in The Gambia and Burkina Faso. The pneumococcal
outbreaks described above underscore the clinical importance of
pneumococcal serotype 1 in sub-SaharanAfrica and show that the
ST 618 clone and clones associated with the ST 217 clonal com-
plex are responsible for outbreaks in the region. Pneumococcal
carriage of these clones among healthy people has been reported
in several countries in sub-Saharan Africa such as The Gambia
(Antonio et al., 2008b) and Nigeria (Adetifa et al., 2012).
Pneumococcal serotype 1 is also an important cause of invasive
disease and epidemics in the developed world (Brueggemann and
Spratt, 2003). However, while pneumococcal serotype 1 infections
in sub-Saharan Africa are more associated with MLST genotypes
STs 217 and 618 (Leimkugel et al., 2005; Yaro et al., 2006; Antonio
et al., 2008b), in Europe and the United States, STs 306 and 227
are the dominant genotypes causing serotype 1 related infections
(Brueggemann and Spratt, 2003). Another example of this situa-
tion is with pneumococcal serotype 3 which is an important cause
of invasive disease in Europe and the United States, as well as in
sub-Saharan Africa; in Europe and the United States, serotype 3
infections are associated with ST 180 (http://speumoniae.mlst.
net/), whereas in sub-Saharan Africa, the infections seem to be
associated with STs 458 and 700 (Adetifa et al., 2012; Donkor
et al., 2013). These observations suggest the possibility of a diver-
gent pneumococcal population in sub-Saharan Africa (compared
to pneumococcal population in the developed world) which has
been elucidated by a recent pneumococcal carriage study by
Donkor et al. (2011) in The Gambia. In this study 148 pneumo-
coccal isolates from children were typed by MLST and 76 STs
were identified. The investigators carried out eBURST analysis
(a method of finding clonal complexes or relationships between
strains by examining MLST profiles) on their isolates in compar-
ison with the pneumococcal MLST global database and observed
that the Gambian isolates formed a divergent and diverse pop-
ulation (Figure 1). The investigators also compared the extent
of genetic recombination in the Gambian pneumococcal pop-
ulation with those of two European pneumococcal populations
from Finland and the UK, and observed that recombination in
the Gambian population (34%) was far higher than those in the
Finnish sample (2%) and UK sample (5%). It was concluded
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FIGURE 1 | Comparison of a Gambian pneumococcal population sample
with that of the global pneumococcal MLST database. The figure was
generated using eBURST (Feil et al., 2004). STs of the Gambian population
are shown in pink, while the blue and yellow colors represent primary
founders and subgroup founders, respectively. Majority of the Gambian
strains are not associated with the major clonal complexes of the MLST
database indicating that the Gambian pneumococcal population sample is
thus divergent (Donkor et al., 2011).
that the high amounts of recombination in the Gambian pneu-
mococcal population accounts for its divergence compared to
pneumococcal samples from other geographical regions. The high
amount of recombination among the Gambian isolates is due to
horizontal gene transfer which is facilitated by the relatively high
rates of multiple pneumococcal carriage in sub-Saharan Africa
(Donkor et al., 2011). The high amount of recombination can
produce novel combinations of alleles at the MLST loci result-
ing in the divergent population observed in the Gambian sample.
Generally, pneumococcal population samples from different parts
of sub-Saharan Africa appear to be similar in population struc-
ture, though some clones have been consistently reported in only
some parts of the sub-region. For example, STs 913, 925, 1737,
2160, and 3310 have so far been reported only in The Gambia,
which could also be attributed to the fact that the pneumococcal
population has been less studied in many parts of sub-Saharan
Africa.
Little is known about molecular epidemiology of the pneumo-
coccus in sub-Saharan Africa though majority of pneumococcal
infections occur in this setting. Lack of molecular typing data of
the pneumococcus in sub-Saharan Africa is mainly due to lack
of facilities as well as technical expertise required for the organ-
ism. Thus capacity building in the form of training personnel on
the pneumococcus, and also providing adequate research funding
constitute a major part of the solution to this problem. Currently,
there is an urgent need for molecular epidemiology data on the
pneumococcus in sub-Saharan Africa given the expected massive
pneumococcal vaccination in the region (PneumoADIP, 2007).
This information is necessary to monitor evolutionary changes
in the pneumococcal population following introduction of pneu-
mococcal vaccines. Trends in evolutionary changes following
pneumococcal vaccination have been documented in developing
countries such as the United States (Brueggemann et al., 2007).
However, the data may not be applicable to sub-Saharan Africa,
as the population structure of the pneumococcus in sub-Saharan
Africa appears to be quite divergent from what is known in the
developed world. It is important to note that the absence of
serotype 1 in the pneumococcal 7-valent vaccine (PCV7) makes
the vaccine highly unsuitable for sub-Saharan Africa given the
role of pneumococcal serotype 1 in epidemics in the sub-region.
Additionally, the use of PCV7 in sub-Saharan Africa could select
for serotype 1 with changes in its population structure, and for
that matter other serotypes not included in the vaccine.
CONCLUSION
Few studies have employed molecular methods to investigate
the pneumococcus in sub-Saharan Africa. Consequently, little
is known about molecular epidemiology of the pneumococcus
in sub-Saharan Africa, though majority of pneumococcal infec-
tions occur in this region. The pneumococcal population in
sub-Saharan Africa appears to be quite divergent from what is
known in the developed world, and pneumococcal serotype 1
related to the ST 618 clone and clones of the ST 217 clonal com-
plex are responsible for outbreaks in sub-Saharan Africa. There
is an urgent need for molecular epidemiology data on the pneu-
mococcus in sub-Saharan Africa to help monitor evolutionary
changes in the pneumococcal population following introduction
of pneumococcal vaccines in the sub region.
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